Molina J M, Oksenhendler E, Beauvais B, Sarfati C, Jaccard A, Derouin F, Modaï J
Division of Infectious Diseases, Hôpital Saint-Louis, Paris, France.
J Infect Dis. 1995 Jan;171(1):245-9. doi: 10.1093/infdis/171.1.245.
Five patients with AIDS had disseminated infection due to Septata intestinalis, a recently described organism. S. intestinalis infection was suspected after detection of spores in stools and urine and confirmed by transmission electron microscopy of duodenal biopsies or of cell culture of urine sediment. Clinical features included chronic diarrhea that was usually associated with fever, cholangitis, sinusitis, bronchitis, or mild bilateral conjunctivitis. Mean CD4 cell count was 22/microL. Patients treated with albendazole (400 mg orally twice a day) for a mean of 19 days had a dramatic and rapid clinical response to therapy. Significant reduction of parasite shedding was also observed during therapy; S. intestinalis was cleared from stools of all patients and from urine of 3. In 2 patients, however, microsporidian spores were detected in feces during follow-up and mild diarrhea recurred. Therefore, albendazole seems to have a significant but transient effect in treatment of S. intestinalis infection.
5例艾滋病患者发生了由肠道Septata菌(一种最近才被描述的微生物)引起的播散性感染。在粪便和尿液中检测到孢子后怀疑存在肠道Septata菌感染,并通过十二指肠活检的透射电子显微镜检查或尿沉渣的细胞培养得以确诊。临床特征包括通常伴有发热的慢性腹泻、胆管炎、鼻窦炎、支气管炎或轻度双侧结膜炎。平均CD4细胞计数为22/μL。接受阿苯达唑(每日口服两次,每次400mg)治疗平均19天的患者对治疗有显著且迅速的临床反应。治疗期间还观察到寄生虫排出显著减少;所有患者的粪便中以及3例患者的尿液中的肠道Septata菌均被清除。然而,在2例患者的随访期间粪便中检测到微孢子虫孢子,并且再次出现轻度腹泻。因此,阿苯达唑在治疗肠道Septata菌感染方面似乎具有显著但短暂的效果。